The Journal of Pediatrics of Korean Medicine (대한한방소아과학회지)

The Association of Korean Oriental Pediatrics (대한한방소아과학회)
권호 표지
DOI QR코드

DOI QR Code

Therapeutic Effects of Yijungtang on Atopic Dermatitis-like Skin Lesions of NC/Nga Mouse Induced by Mite Antigen

이중탕(理中湯)이 Mite Antigen으로 유발된 NC/Nga 생쥐의 아토피 피부염에 미치는 영향

  • Seo, Hui-Yeon (Department of Pediatrics, College of Oriental Medicine, Daejeon University) ;
  • Han, Jae-Kyung (Department of Pediatrics, College of Oriental Medicine, Daejeon University) ;
  • Kim, Yun-Hee (Department of Pediatrics, College of Oriental Medicine, Daejeon University)
  • 서희연 (대전대학교 한의과대학 소아과학교실) ;
  • 한재경 (대전대학교 한의과대학 소아과학교실) ;
  • 김윤희 (대전대학교 한의과대학 소아과학교실)
  • Received : 2011.03.21
  • Accepted : 2011.04.22
  • Published : 2011.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The purpose of this study is to investigate the effects of Yijungtang(YJT) on atopic dermatitis in an in-vitro and in-vivo experiment using a RBL-2H3 mast cells and a NC/Nga atopic dermatitis mouse. Methods: In-vitro experiment, IL-4, IL-13 mRNA expression were evaluated by a real-time PCR, IL-4, IL-13 production by ELISA and transcription factor as GATA-1, GATA-2, NF-AT1, NF-AT2, AP-1 and NF-kB by western blotting. In-vivo experiment, clinical skin score we evaluated by, hematology and Serum total IgE and IgG1 of NC/Nga atopic dermatitis mouse, cytokine level, total number of cell, Immunohistochemical staining and Histological features of auxiliary lymph node(ALN), draining lymph node(DLN), peripheral blood mononuclear cells(PBMCs) and dorsal skin tissue in NC/Nga mouse. Results: YJT decreased IL-4, IL-13 mRNA expression, IL-4, IL-13 production and prominently decreased the expression of mast cell specific transcription factors including GATA-2, NF-AT2, c-Fos and NF-kB. YJT oral administration reduced the levels of skin severity scores. It also decreased the level of inflammatory cytokines such as IL-5, IL-13, histamine and IgE in the serum. It elevated IFN-gamma level in the spleenocyte culture supernatant but decreased. $CD3e^+$, $CD19^+$, $CD4^+$, $CD8^+$, $CD3e^+CD69^+$, $CD11b^+Gr-1^+$, $CCR3^+$ in the PBMCs, $CD4^+$, $CD8^+$, $CD3e^+CD69^+$, $B220^+CD23^+$ in the ALN, $CD4^+$, $CD3e^+CD69^+$ in the ALN and $CD4^+$, $CD11b^+Gr-1^+$ in the dorsal skin. Histological examination showed that infiltration levels of immune cells in the skin of AD-induced NC/Nga mice were much improved by YJT oral administration. Conclusions: The anti-allergic activities of YJT may be mediated by down-regulation of Th2 cytokines, such as IL-4 and IL-13, through the regulation GATA-2, NF-AT2 and NF-kB transcription factors in mast cells. YJT would be regulate molecular mediators and immune cells which are functionally associated with atopic dermatitis induced in NC/Nga mice, and may play an important role in recovering AD symptoms.

Keywords

References

  1. 홍창의. 소아과학. 서울:대한교과서주식회사. 2007; 1142-7.
  2. 박용민. 아토피피부염 병태생리에 대한 최신지견. 소아알레르기 호흡기 학회지. 2006;16(3):189-96.
  3. 지혜미, 김경원, 김창수, 손명현, 신동천, 김규언. 2006 년 초등학생의 알레르기 질환 유병률의 전국적 역학조사. 소아알레르기 호흡기학회지. 2009;19(2):165-72.
  4. Arellano FM, Wentworth CE, Arana A. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J. Invest. Dermatol. 2007;127:808-16. https://doi.org/10.1038/sj.jid.5700622
  5. Furue M, Terao H, Moroi Y, Koga T, Kubota Y, Nakayama J, Furukawa F, Tanaka Y, Katayama I, Kinukawa N, Nose Y, Urabe K. Dosage and adverse effects of topical tacrolimus and steroids in daily management of atopic dermatitis. J Dermatol. 2004;31(4):277-83. https://doi.org/10.1111/j.1346-8138.2004.tb00673.x
  6. 이원세. 新方新編. 서울:대성의학사. 2001:114.
  7. 서희연, 한재경, 김윤희. 이중탕이 IgE가 과잉생성되고 피부염이 유발된 NC/Nga생쥐에서 IFN-$\gamma$ 반응에 의한 Th2 세포분화 억제에 미치는 영향. 대한한방소아과학회지. 2009;23(1):1-22.
  8. Ishiyama M, Miyazono Y, Sasamoto K, Ohkura Y, Ueno K. A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta. 1997;44(7):1299-305. https://doi.org/10.1016/S0039-9140(97)00017-9
  9. Oshio T, Sasaki Y, Funakoshi-Tago M, Aizu-Yokota E, Sonoda Y, Matsuoka H, Kasahara T. Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment. Int Immunopharmacol. 2009; 9(4):403-11. https://doi.org/10.1016/j.intimp.2008.12.013
  10. FONIO A. Justifying my method of separation of structural elements of thrombocytes. Wien Z Inn Med. 1956;37(6):255-6.
  11. Goka AK, Farthing MJ. The use of 3,3',5,5'-tetramethylbenzidine as a peroxidase substrate in microplate enzyme- linked immunosorbent assay. J Immunoassay. 1987; 8(1):29-41. https://doi.org/10.1080/01971528708063053
  12. Witney AA, Doolan DL, Anthony RM, Weiss WR, Hoffman SL, Carucci DJ. Determining liver stage parasite burden by real time quantitative PCR as a method for evaluating pre-erythrocytic malaria vaccine efficacy. Mol Biochem Parasitol. 2001;118(2):233-45. https://doi.org/10.1016/S0166-6851(01)00372-3
  13. Otsuka H, Dolovich J, Befus D, Bienenstock J, Denburg J. Peripheral blood basophils, basophil progenitors, and nasal metachromatic cells in allergic rhinitis. Am Rev Respir Dis. 1986;133(5):757-62.
  14. Dr Joanne Clough. 알레르기. 서울:아카데미아. 2005: 15-21.
  15. Schultz-Larsen F, Hanifin JM. Epidemiology of atopic dermatitis, Immunol. Allergy Clin. North Am. 2002; 22:1-24.
  16. 임정우, 문경상, 공도연, 편복양. 아토피피부염 환자의 발병과 치료에 대한 실태 조사. 소아알레르기 및 호흡기 학회지. 2006;15(1):44-52.
  17. 오재원, 김규원,. 편복양. 1995년과 2000년의 학동기와 2003년 학동전기 소아에서의 아토피 피부염의 역학적 변화에 관한 전국적인 연구. 소아알레르기 및 호흡기. 2003;13(4):227-37.
  18. 이해성, 김종서, 편복양. 소아 아토피 피부염의 빈도와 원인의 변화. 소아알레르기 및 호흡기. 2002;12(4):263-70.
  19. 김정희. 아토피피부염의 최신지견. 소아 알레르기 및 호흡기. 2004;14(1):12-23.
  20. Sturgil S, Bernard LA. Atopic dermatitis update. Curr Opin Pediatr. 2004;16:396-401. https://doi.org/10.1097/01.mop.0000133632.33920.dd
  21. 이윤미, 황선욱. 학령전기와 학령기 아동에서의 아토피 피부염 유병률과 위험인자. 아동간호학회지. 2008;14(3):285-94.
  22. 이종근, 이호성, 하진실, 박동진, 백도현, 하권철. 창원시 학동 전기 소아들의 아토피 피부염 유병률과 그원인에 관한 연구. 한국환경보건학회지. 2009;35(3): 169-77.
  23. Dei-Cas I, Dei-Cas P, Acuna K. Atopic dermatitis and risk factors in poor children from Great Buenos Aires, Argentina. Clin Exp Dermatol. 2009;34(3):299-303. https://doi.org/10.1111/j.1365-2230.2008.02916.x
  24. Moore MM, Rifas-Shiman SL, Rich-Edwards JW, Kleinman KP, Camargo CA Jr, Gold DR, Weiss ST, Gillman MW. Perinatal predictors of atopic dermatitis occurring in the first six months of life. Pediatrics. 2004;113(3 Pt 1):468-74. https://doi.org/10.1542/peds.113.3.468
  25. van Beijsterveldt CE, Boomsma DI. Genetics of parentally reported asthma, eczema and rhinitis in 5-yr-old twins,. Eur Respir J. 2007;29(3):516-21. https://doi.org/10.1183/09031936.00065706
  26. Zutavern A, Hirsch T, Leupold W, Weiland S, Keil U, von Mutius E. Atopic dermatitis, extrinsic atopic dermatitis and the hygiene hypothesis: results from a cross-sectional study. Clin Exp Allergy. 2005;35(10):1301-8. https://doi.org/10.1111/j.1365-2222.2005.02350.x
  27. Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Ehrlich-Kautzky E, Schou C, Krishnaswamy G, Beaty TH. Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science. 1994;20;264(5162):1152-6. https://doi.org/10.1126/science.8178175
  28. 김성현, 한덕현, 박혜진, 변지연, 최유원, 최혜영, 명기범. 소아청소년 아토피피부염 환자의 애착반응 및 부모의 삶의 질과의 관계. 대한피부과학회지. 2008; 46(11):1457-62.
  29. 강명화, 김은영, 최미경. 아토피 피부염 미취학아동의 식습관 및 영양섭취상태. 대한지역사회영양학회 춘추계학술대회지. 2008;2:124
  30. 박철종, 이종욱, 김태윤, 김진우, 김정원. 아토피피부염에 대한 환경인자의 영향. 대한천식 및 알레르기학회 추계학술대회 초록집. 1995;1995:551.
  31. 신경옥, 박현서, 오세영. 학령 전 아동에서 아토피피부염의 영향, 행동 위험 요인 분석. 한국영양학회지. 2006;39(8):795-800.
  32. 안성구, 박병덕, 원진형, 성열오, 천승현. 아토피 피부염. 서울:퍼시픽출판사. 2007:32.
  33. Cooper KD. Atopic dermatitis. recent trends in patho genesis and therapy. J Invest Dermatol. 1994;102(1): 128-37. https://doi.org/10.1111/1523-1747.ep12371746
  34. Horsmanheimo L, Harvima IT, Jarvikallio A, Harvima RJ, Naukkarinen A, Horsmanheimo M. Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol. 1994;131(3):348-53. https://doi.org/10.1111/j.1365-2133.1994.tb08522.x
  35. Renz H, Jujo K, Bradley KL, Domenico J, Gelfand EW, Leung DY. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J Invest Dermatol. 1992;99 (4):403-8. https://doi.org/10.1111/1523-1747.ep12616114
  36. 김세종. 면역학. 서울:고려의학. 2002:257-64.
  37. Foster PS, Martinez-Moczygemba M, Huston DP, Corry DB. Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease. Pharmacol Ther. 2002;94(3): 253-624. https://doi.org/10.1016/S0163-7258(02)00220-6
  38. Ricci M, Rossi O, Bertoni M, Matucci A. The importance of Th2-like cells in the pathogenesis of airway allergic inflammation. Clin Exp Allergy. 1993;23(5):360-9. https://doi.org/10.1111/j.1365-2222.1993.tb00340.x
  39. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today. 1996;17(3):138-46. https://doi.org/10.1016/0167-5699(96)80606-2
  40. Kim JT. Evaluation of inflammation in childhood asthma; Non-invasive measurement. J Korean Pediatr Soc. 2001; 44(3):334-9.
  41. Moller A, Henz BM, Grutzkau A, Lippert U, Aragane Y, Schwarz T, Kruger-Krasagakes S. Comparative cytokine gene expression: regulation and release by human mast cells. Immunology. 1998;93(2):289-95.
  42. Valent P, Spanblol E, Sperr WR, Sillaber C, Zsebo KM, Agis H, Strobl H, Geissler K, Bettelheim P, Lechner K. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood. 1992:1;80(9):2237-45.
  43. Schroeder JT, MacGlashan DW Jr, Kagey-Sobotka A, White JM, Lichtenstein LM. Cytokine generation by human basophils. J Allergy Clin Immunol. 1994;94(6 Pt 2):1189-95. https://doi.org/10.1016/0091-6749(94)90331-X
  44. Agnello D, Lankford CS, Bream J, Morinobu A, Gadina M, O'Shea JJ, Frucht DM. Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol. 2003;23(3):147-61. https://doi.org/10.1023/A:1023381027062
  45. Weber A, Knop J, Maurer M. Pattern analysis of human cutaneous mast cell populations by total body surface mapping. Br J Dermatol. 2003;148(2):224-8. https://doi.org/10.1046/j.1365-2133.2003.05090.x
  46. Kim HM, Lee YM. Role of TGF-beta 1 on the IgE-dependent anaphylaxis reaction. J Immunol. 1999;15;162(8): 4960-5.
  47. Gibbs BF, Haas H, Wolff HH, Grabbe J. Early IgE-dependent release of IL-4 and IL-13 from leukocytes is restricted to basophils: a comparison with other granulocytes and mononuclear cells. Inflamm Res. 2000;49 (1):9-10. https://doi.org/10.1007/PL00000197
  48. Katz HR, Stevens RL, Austen KF. Heterogeneity of mammalian mast cells differentiated in vivo and in vitro. J Allergy Clin Immunol. 1985;76(2 Pt 2):250-9. https://doi.org/10.1016/0091-6749(85)90638-4
  49. Humbert M, Grant JA, Taborda-Barata L, Durham SR, Pfister R, Menz G. High-affinity IgE receptor (Fcepsiolon RI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med. 1996;153:1931-7. https://doi.org/10.1164/ajrccm.153.6.8665058
  50. Marshall JS. Mast-cell responses to pathogens. Nat Rev Immunol, 2004;4(10):787-99. https://doi.org/10.1038/nri1460
  51. Mekori YA, Metcalfe DD. Mast cells in innate immunity. Immunol Rev. 2000;173:131-40. https://doi.org/10.1034/j.1600-065X.2000.917305.x
  52. Petersen LJ, Mosbech H, Skov PS. Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique: characterization of factors influencing histamine releasability. J Allergy Clin Immunol. 1996;97(2):672-9. https://doi.org/10.1016/S0091-6749(96)70313-5
  53. Matsubara M, Masaki S, Ohmori K, Karasawa A, Hasegawa K. Differential regulation of IL-4 expression and degranulation by anti-allergic olopatadine in rat basophilic leukemia (RBL-2H3) cells. Biochem Pharmacol. 2004;67(7):1315-26. https://doi.org/10.1016/j.bcp.2003.12.008
  54. Weiss DL, Hural J, Tara D, Timmerman LA, Henkel G, Brown MA. Nuclear factor of activated T cells is associated with a mast cell interleukin 4 transcription complex. Mol Cell Biol. 1996;16(1):228-35. https://doi.org/10.1128/MCB.16.1.228
  55. Hirasawa N, Sato Y, Fujita Y, Ohuchi K. Involvement of a phosphatidylinositol 3-kinase-p38 mitogen activated protein kinase pathway in antigen-induced IL-4 production in mast cells. Biochim Biophys Acta. 2000;3;1456(1): 45-55. https://doi.org/10.1016/S0005-2728(99)00104-8
  56. Masuda A, Yoshikai Y, Kume H, Matsuguchi T. The interaction between GATA proteins and activator protein- 1 promotes the transcription of IL-13 in mast cells. J Immunol. 2004;1;173(9):5564-73. https://doi.org/10.4049/jimmunol.173.9.5564
  57. Toru H, Pawankar R, Ra C, Yata J, Nakahata T. Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells. J Allergy Clin Immunol. 1998;102(3): 491-502. https://doi.org/10.1016/S0091-6749(98)70140-X
  58. 吳謙. 醫宗金鑑(下). 北京:人民衛生出版社. 1982: 443-4.
  59. 巢元方. 巢氏諸病源候論. 서울:大星文化社. 1992: 251-3.
  60. 王伯岳, 江育仁. 中醫兒科學. 上海:上海科學技術出版社. 1984:203-4.
  61. 손국호, 이재근, 지선영. 아토피피부염의 한의학적 변증에 대한 문헌적 고찰. 동서의학. 2009;34(4):15-24.
  62. 中醫兒科臨床手冊. 上海中醫學院. 上海:上海科學技術出版社. 1980:203-4.
  63. 王沛, 李日慶, 張燕生. 中醫臨床大系 中醫外科治療大成. 石家莊:河北科學技術出版社. 1997:544-6.
  64. 김덕곤 외 7명. 동의 소아과학. 서울:정담. 2002:660-4.
  65. McNagny K, Graf T. Making eosinophils through subtle shifts in transcription factor expression. J Exp Med. 2002;3;195(11):43-7. https://doi.org/10.1084/jem.20011145
  66. Nerlov C, Graf T. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 1998;1;12(15):2403-12. https://doi.org/10.1101/gad.12.15.2403
  67. Hirasawa R, Shimizu R, Takahashi S, Osawa M, Takayanagi S, Kato Y, Onodera M, Minegishi N, Yamamoto M, Fukao K, Taniguchi H, Nakauchi H, Iwama A. Essential and instructive roles of GATA factors in eosinophil development. J Exp Med. 2002;3;195(11): 1379-86. https://doi.org/10.1084/jem.20020170
  68. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol. 1997;15:707-47. https://doi.org/10.1146/annurev.immunol.15.1.707
  69. Latinis KM, Norian LA, Eliason SL, Koretzky GA. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J Biol Chem. 1997;12;272(50):31427-34. https://doi.org/10.1074/jbc.272.50.31427
  70. Klein M, Klein-Hessling S, Palmetshofer A, Serfling E, Tertilt C, Bopp T, Heib V, Becker M, Taube C, Schild H, Schmitt E, Stassen M. Specific and redundant roles for NFAT transcription factors in the expression of mast cell-derived cytokines. J Immunol. 2006;15;177(10): 6667-74. https://doi.org/10.4049/jimmunol.177.10.6667
  71. Lewin I, Nechushtan H, Ke Q, Razin E. Regulation of AP-1 expression and activity in antigen-stimulated mast cells: the role played by protein kinase C and the possible involvement of Fos interacting protein. Blood. 1993;15; 82(12):3745-51.
  72. Min YD, Choi CH, Bark H, Son HY, Park HH, Lee S, Park JW, Park EK, Shin HI, Kim SH. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflamm Res. 2007;56(5):210-5. https://doi.org/10.1007/s00011-007-6172-9
  73. Reber L, Vermeulen L, Haegeman G, Frossard N. Ser276 phosphorylation of NF-$\kappa$B p65 by MSK1 controls SCF expression in inflammation, PLoS One. 2009;4(2):e4393. https://doi.org/10.1371/journal.pone.0004393
  74. Urban MB, Schreck R, Baeuerle PA. NF-kappaB contacts DNA by a heterodimer of the p50 and 065 subunit. EMBO J. 1991;10(7):1817-25.
  75. Baeuerle PA, Baltimore D. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor. Cell. 1988;22;53(2): 211-7. https://doi.org/10.1016/0092-8674(88)90382-0
  76. Baeuerle PA. The inducible transcription activator NF-$\kappa$B: regulation by distinct protein subunits. Biochim Biophys Acta. 1991;16;1072(1):63-80.
  77. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW, Ra C. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol. 1997;9(3):461-6. https://doi.org/10.1093/intimm/9.3.461
  78. Bellanti JA. Cytokines and allergic diseases: clinical aspects. Allergy Asthma Proc. 1998;19(6):337-41. https://doi.org/10.2500/108854198778612735
  79. Yawalkar N, Uguccioni M, Schärer J, Braunwalder J, Karlen S, Dewald B, Braathen LR, Baggiolini M. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol. 1999;113(1):43-8. https://doi.org/10.1046/j.1523-1747.1999.00619.x
  80. Huang B, Pan PY, Li Q, Sato AI, Levy DE, Bromberg J, Divino CM, Chen SH. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 2006;15;66(2):1123-31. https://doi.org/10.1158/0008-5472.CAN-05-1299

Cited by

  1. Simultaneous quantification and inhibitory effect on LDL oxidation of the traditional Korean medicine, Leejung-tang vol.14, pp.1, 2014, https://doi.org/10.1186/1472-6882-14-3
  2. The Effects of Dictamni Radicis Cortex Extracts on DNCB Induced Atopic Dermatitis-like Skin Lesions of NC/Nga Mouse vol.28, pp.4, 2014, https://doi.org/10.7778/jpkm.2014.28.4.001
  3. HPLC 분석법을 이용한 이중탕(理中湯) 제제의 품질평가 vol.31, pp.3, 2011, https://doi.org/10.6116/kjh.2016.31.3.29.